Bayer, a leading life sciences company, shed light on digitally transforming the experience of health at the Digitrans 2019 – The Digital Transformation Forum that held recently in Dubai. Taking this objective forward, Eugene Borukhovich, Global Head Digital Health at Bayer, hosted a session titled “Pharma Digital Transformation: Changing the Experience of Health”.
Eugene touched upon key trends impacting the healthcare industry, the importance of emerging technologies such as Artificial Intelligence and Machine Learning in enhancing healthcare solutions and start-up-driven healthcare transformation through Bayer’s G4A global group.
Within healthcare, start-ups continue to redefine and rebuild the overall patient experience. Their agile nature has given rise to digital solutions and services that allow customers to gain optimum control of their healthcare, meeting the growing demands of digital customers.
Through G4A, Bayer continues to empower start-ups to change the experience of health. Established in more than 35 countries, the G4A collaborates with start-ups and healthcare technology companies to co-create growth opportunities within the healthcare industry and develop innovative patient-focused solutions. In addition, through this program, Bayer also offers mentorship, healthcare funding and access to exclusive industry networks.
“Digital transformation has brought sweeping changes within the healthcare industry. It has changed the way we work, do business and meet customer expectations,” said Borukhovich. “Keeping this in mind, Digitrans 2019 served as an ideal platform to lay emphasis on the importance of leveraging emerging technologies and the potential demonstrated by start-ups accelerate the cycle of innovation within the healthcare industry, while keeping pace with the evolving digital age.”
With the UAE channelling their efforts towards reshaping the healthcare industry on a whole, with its G4A program aims to help the country make a quantum leap to be at the forefront of this transformation.